eGenesis Reports Kidney Xenotransplantation Clinical Progress
Cambridge, Massachusetts — September 3, 2026 eGenesis announced an important clinical update from its ongoing Expanded Access study of...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, Massachusetts — September 3, 2026 eGenesis announced an important clinical update from its ongoing Expanded Access study of...
GAINESVILLE, Fla., July 17, 2026 UF Health has once again earned national recognition for its lung transplant program, receiving...
SCHLIEREN / ZURICH, Switzerland, June 5, 2026 Memo Therapeutics AG announced additional positive analyses from its Phase II SAFE...
DULUTH, Georgia, May 28, 2026 Bridge to Life™ Ltd. has announced the publication of landmark clinical trial results in...
COPENHAGEN, Denmark — May 28, 2026 Synklino A/S announced that the first patient has been dosed in a first-in-human...
BRUSSELS, Belgium, May 19, 2026 SERB Pharmaceuticals and Hansa Biopharma have announced a strategic €115 million licensing agreement granting...
